BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30465924)

  • 21. Novel third-generation water-soluble noscapine analogs as superior microtubule-interfering agents with enhanced antiproliferative activity.
    Henary M; Narayana L; Ahad S; Gundala SR; Mukkavilli R; Sharma V; Owens EA; Yadav Y; Nagaraju M; Hamelberg D; Tandon V; Panda D; Aneja R
    Biochem Pharmacol; 2014 Nov; 92(2):192-205. PubMed ID: 25124704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of N-substituted noscapine analogues.
    DeBono AJ; Xie JH; Ventura S; Pouton CW; Capuano B; Scammells PJ
    ChemMedChem; 2012 Dec; 7(12):2122-33. PubMed ID: 23055449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents for the management of breast cancer.
    Meher RK; Pragyandipta P; Reddy PK; Pedaparti R; Kantevari S; Naik PK
    J Biomol Struct Dyn; 2022; 40(23):13136-13153. PubMed ID: 34583618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 9-Arylimino noscapinoids as potent tubulin binding anticancer agent: chemical synthesis and cellular evaluation against breast tumour cells.
    Patel AK; Meher RK; Nagireddy PK; Pragyandipta P; Pedapati RK; Kantevari S; Naik PK
    SAR QSAR Environ Res; 2021 Apr; 32(4):269-291. PubMed ID: 33687299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico inspired design and synthesis of a novel tubulin-binding anti-cancer drug: folate conjugated noscapine (Targetin).
    Naik PK; Lopus M; Aneja R; Vangapandu SN; Joshi HC
    J Comput Aided Mol Des; 2012 Feb; 26(2):233-47. PubMed ID: 22170255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of noscapine derivatives as potential β-tubulin inhibitors.
    Nemati F; Salehi P; Bararjanian M; Hadian N; Mohebbi M; Lauro G; Ruggiero D; Terracciano S; Bifulco G; Bruno I
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127489. PubMed ID: 32784088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,3-Benzodioxole-Modified Noscapine Analogues: Synthesis, Antiproliferative Activity, and Tubulin-Bound Structure.
    Yong C; Devine SM; Abel AC; Tomlins SD; Muthiah D; Gao X; Callaghan R; Steinmetz MO; Prota AE; Capuano B; Scammells PJ
    ChemMedChem; 2021 Sep; 16(18):2882-2894. PubMed ID: 34159741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piperlongumine (piplartine) and analogues: Antiproliferative microtubule-destabilising agents.
    Meegan MJ; Nathwani S; Twamley B; Zisterer DM; O'Boyle NM
    Eur J Med Chem; 2017 Jan; 125():453-463. PubMed ID: 27689728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of novel and improved antimitotic agents derived from noscapine.
    Anderson JT; Ting AE; Boozer S; Brunden KR; Crumrine C; Danzig J; Dent T; Faga L; Harrington JJ; Hodnick WF; Murphy SM; Pawlowski G; Perry R; Raber A; Rundlett SE; Stricker-Krongrad A; Wang J; Bennani YL
    J Med Chem; 2005 Nov; 48(23):7096-8. PubMed ID: 16279766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural investigations into the binding mode of a novel noscapine analogue, 9-(4-vinylphenyl) noscapine, with tubulin by biochemical analyses and molecular dynamic simulations.
    Mahaddalkar T; Naik PK; Choudhary S; Manchukonda N; Kantevari S; Lopus M
    J Biomol Struct Dyn; 2017 Aug; 35(11):2475-2484. PubMed ID: 27576773
    [No Abstract]   [Full Text] [Related]  

  • 31. Design, synthesis and biological evaluation of di-substituted noscapine analogs as potent and microtubule-targeted anticancer agents.
    Mishra RC; Gundala SR; Karna P; Lopus M; Gupta KK; Nagaraju M; Hamelberg D; Tandon V; Panda D; Reid MD; Aneja R
    Bioorg Med Chem Lett; 2015; 25(10):2133-40. PubMed ID: 25891106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiproliferative Noscapinoids Bearing an Amidothiadiazole Scaffold as Apoptosis Inducers: Design, Synthesis and Molecular Docking.
    Kumar Pedapati R; Pragyandipta P; Pranathi Abburi N; Chirra N; Kantevari S; Naik PK
    Chem Biodivers; 2023 Feb; 20(2):e202201089. PubMed ID: 36690497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational design, synthesis and biological evaluations of amino-noscapine: a high affinity tubulin-binding noscapinoid.
    Naik PK; Chatterji BP; Vangapandu SN; Aneja R; Chandra R; Kanteveri S; Joshi HC
    J Comput Aided Mol Des; 2011 May; 25(5):443-54. PubMed ID: 21544622
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Meher RK; Nagireddy PKR; Pragyandipta P; Kantevari S; Singh SK; Kumar V; Naik PK
    J Biomol Struct Dyn; 2022 Sep; 40(15):6725-6736. PubMed ID: 33627059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational design of novel anti-microtubule agent (9-azido-noscapine) from quantitative structure activity relationship (QSAR) evaluation of noscapinoids.
    Santoshi S; Naik PK; Joshi HC
    J Biomol Screen; 2011 Oct; 16(9):1047-58. PubMed ID: 21972248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine.
    Zhou J; Gupta K; Yao J; Ye K; Panda D; Giannakakou P; Joshi HC
    J Biol Chem; 2002 Oct; 277(42):39777-85. PubMed ID: 12183452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Copper(I) mediated facile synthesis of potent tubulin polymerization inhibitor, 9-amino-α-noscapine from natural α-noscapine.
    Manchukonda NK; Sridhar B; Naik PK; Joshi HC; Kantevari S
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2983-7. PubMed ID: 22425569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The synthesis and biological evaluation of multifunctionalised derivatives of noscapine as cytotoxic agents.
    Debono AJ; Mistry SJ; Xie J; Muthiah D; Phillips J; Ventura S; Callaghan R; Pouton CW; Capuano B; Scammells PJ
    ChemMedChem; 2014 Feb; 9(2):399-410. PubMed ID: 24339417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational design of the microtubule-targeting anti-breast cancer drug EM015.
    Aneja R; Lopus M; Zhou J; Vangapandu SN; Ghaleb A; Yao J; Nettles JH; Zhou B; Gupta M; Panda D; Chandra R; Joshi HC
    Cancer Res; 2006 Apr; 66(7):3782-91. PubMed ID: 16585205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic interaction of N-3-Br-benzyl-noscapine and docetaxel abrogates oncogenic potential of breast cancer cells.
    Dash SG; Kantevari S; Pandey SK; Naik PK
    Chem Biol Drug Des; 2021 Sep; 98(3):466-479. PubMed ID: 34107169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.